Federal contractor · CORTE MADERA, CA

OPHIREX, INC

No contract obligations recorded for OPHIREX, INC in FY2026. Since FY2017: $46.4M.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
W452WY5E2JQ9
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 177.3KFY2017
  2. 597.8KFY2018
  3. 975.5KFY2019
  4. 15.7MFY2020
  5. 4.4MFY2021
  6. 14MFY2022
  7. 6.5MFY2023
  8. 4.5MFY2024
  9. -645KFY2025

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for OPHIREX, INC in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

OPHIREX, INC received $0 in federal assistance in FY2026, on 2 actions (0 new awards), −100% vs FY2025.

Assistance · FY2026
$0
New awards
0
Actions
2
Since FY2023
$2.9M

Assistance by fiscal year

  1. 894.5KFY2023
  2. 886.3KFY2024
  3. 1.1MFY2025
  4. 0FY2026

Largest awards

  1. DEVELOPMENT OF INTRAVENOUS VARESPLADIB, A PHOSPHOLIPASE A2 INHIBITOR, FOR THE TREATMENT OF SNAKEBITE ENVENOMING - 1 PROJECT SUMMARY 2 3 IN…$2.9M
    93.103 · Food and Drug Administration Research· Food and Drug Administration· Project grant· Sep 20, 2023 – Aug 13, 2026· R01FD007839

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2023–FY2026.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. INTERNATIONAL DATA SYSTEMS LLC$4M−100% in FY2026
    ANCHORAGE, AK · 100.0% of this company's obligations are in markets they both serveDefense Health Agency · Scientific research and development services
  2. UNIVERSITY OF BIRMINGHAM$4M−100% in FY2026
    BIRMINGHAM, GBR · 100.0% of this company's obligations are in markets they both serveDefense Health Agency · Scientific research and development services
  3. NUSHORES BIOSCIENCES LLC$4.3M
    LITTLE ROCK, AR · 100.0% of this company's obligations are in markets they both serveDefense Health Agency · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.